<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(11)</volume><submitter>Cortez-Trejo MC</submitter><pubmed_abstract>Pomegranate (PMG; &lt;i>Punica granatum&lt;/i> L.) fruits possess a well-balanced nutrient/phytochemical composition, with proven adjuvant benefits in experimental cancer chemotherapy; however, such bioactivity could be affected by PMG's phenogenotype (varietal). Here, the chemical and phytochemical (UPLC-DAD-MS&lt;sup>2&lt;/sup>) composition, antioxidant capacity and anticancer potential [in vitro (MTT assay) and in silico (foodinformatics)] of three PMG fruits of different aryl color [red (cv. Wonderful), pink (cv. Molar de Elche), and white (cv. Indian)] were evaluated. The macro/micronutrient (ascorbic acid, tocols, carotenoids), organic acid (citric/malic), and polyphenol content were changed by PMG's varietal and total antioxidant activity (ABTS, alcoholic &amp;gt; hexane extract) in the order of red &amp;gt; pink &amp;gt; white. However, their in vitro cytotoxicity was the same (IC&lt;sub>50&lt;/sub> &amp;gt; 200 μg.mL&lt;sup>-1&lt;/sup>) against normal (retinal) and cancer (breast, lung, colorectal) cell lines. Sixteen major phytochemicals were tentatively identified, four of them with a high GI absorption/bioavailability score [Ellagic (pink), vanillic (red), gallic (white) acids, D-(+)-catechin (white)] and three of them with multiple molecular targets [Ellagic (52) &amp;gt; vanillic (32) &amp;gt; gallic (23)] associated with anticancer (at initiation and promotion stages) activity. The anticancer potential of the PMG fruit is phenogenotype-specific, although it could be more effective in nutraceutical formulations (concentrates).</pubmed_abstract><journal>Biomolecules</journal><pagination>1649</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9687934</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Potential Anticancer Activity of Pomegranate (&lt;i>Punica granatum&lt;/i> L.) Fruits of Different Color: In Vitro and In Silico Evidence.</pubmed_title><pmcid>PMC9687934</pmcid><pubmed_authors>Dufoo-Hurtado E</pubmed_authors><pubmed_authors>Olivas-Aguirre FJ</pubmed_authors><pubmed_authors>Wall-Medrano A</pubmed_authors><pubmed_authors>Cortez-Trejo MC</pubmed_authors><pubmed_authors>Mendoza S</pubmed_authors><pubmed_authors>Villegas-Quintero H</pubmed_authors><pubmed_authors>Castaneda-Moreno R</pubmed_authors><pubmed_authors>Medina-Franco JL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Potential Anticancer Activity of Pomegranate (&lt;i>Punica granatum&lt;/i> L.) Fruits of Different Color: In Vitro and In Silico Evidence.</name><description>Pomegranate (PMG; &lt;i>Punica granatum&lt;/i> L.) fruits possess a well-balanced nutrient/phytochemical composition, with proven adjuvant benefits in experimental cancer chemotherapy; however, such bioactivity could be affected by PMG's phenogenotype (varietal). Here, the chemical and phytochemical (UPLC-DAD-MS&lt;sup>2&lt;/sup>) composition, antioxidant capacity and anticancer potential [in vitro (MTT assay) and in silico (foodinformatics)] of three PMG fruits of different aryl color [red (cv. Wonderful), pink (cv. Molar de Elche), and white (cv. Indian)] were evaluated. The macro/micronutrient (ascorbic acid, tocols, carotenoids), organic acid (citric/malic), and polyphenol content were changed by PMG's varietal and total antioxidant activity (ABTS, alcoholic &amp;gt; hexane extract) in the order of red &amp;gt; pink &amp;gt; white. However, their in vitro cytotoxicity was the same (IC&lt;sub>50&lt;/sub> &amp;gt; 200 μg.mL&lt;sup>-1&lt;/sup>) against normal (retinal) and cancer (breast, lung, colorectal) cell lines. Sixteen major phytochemicals were tentatively identified, four of them with a high GI absorption/bioavailability score [Ellagic (pink), vanillic (red), gallic (white) acids, D-(+)-catechin (white)] and three of them with multiple molecular targets [Ellagic (52) &amp;gt; vanillic (32) &amp;gt; gallic (23)] associated with anticancer (at initiation and promotion stages) activity. The anticancer potential of the PMG fruit is phenogenotype-specific, although it could be more effective in nutraceutical formulations (concentrates).</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-05T15:21:37.228Z</modification><creation>2025-04-05T15:21:37.228Z</creation></dates><accession>S-EPMC9687934</accession><cross_references><pubmed>36358999</pubmed><doi>10.3390/biom12111649</doi></cross_references></HashMap>